Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1686102-84-0

Post Buying Request

1686102-84-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1686102-84-0 Usage

General Description

(4-(4-(2,2,2-trifluoroethyl)phenoxy)phenyl)methanol, also known as BHT-920, is a chemical compound that is used as a selective estrogen receptor modulator (SERM). It has been studied for its potential therapeutic effects in the treatment of osteoporosis and breast cancer, as well as its role in promoting bone health and preventing bone loss. BHT-920 exhibits a high affinity for estrogen receptors and has been found to have an estrogenic effect on bone tissue. Additionally, it has been shown to have antiestrogenic effects in certain breast cancer cell lines. Studies have also suggested that BHT-920 may have potential applications in the treatment of other estrogen-related conditions. Overall, research on (4-(4-(2,2,2-trifluoroethyl)phenoxy)phenyl)methanol points to its promising pharmacological properties and potential as a therapeutic agent.

Check Digit Verification of cas no

The CAS Registry Mumber 1686102-84-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,8,6,1,0 and 2 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1686102-84:
(9*1)+(8*6)+(7*8)+(6*6)+(5*1)+(4*0)+(3*2)+(2*8)+(1*4)=180
180 % 10 = 0
So 1686102-84-0 is a valid CAS Registry Number.

1686102-84-0Downstream Products

1686102-84-0Relevant articles and documents

Synthesis and Structure-Activity Relationships for Extended Side Chain Analogues of the Antitubercular Drug (6 S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5 H -imidazo[2,1- b ][1,3]oxazine (PA-824)

Palmer, Brian D.,Sutherland, Hamish S.,Blaser, Adrian,Kmentova, Iveta,Franzblau, Scott G.,Wan, Baojie,Wang, Yuehong,Ma, Zhenkun,Denny, William A.,Thompson, Andrew M.

, p. 3036 - 3059 (2015/04/27)

Novel extended side chain nitroimidazooxazine analogues featuring diverse linker groups between two aryl rings were studied as a potential strategy to improve solubility and oral activity against chronic infection by Mycobacterium tuberculosis. Both lipop

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1686102-84-0